Skip to content

Development and Validation of a Novel Eye-Tracking Software-based Platform to Extract Oculometric Measures

Development and Validation of a Novel Eye-Tracking Software-based Platform to Extract Oculometric Measures

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05476523
Enrollment
2000
Registered
2022-07-27
Start date
2022-07-22
Completion date
2026-12-31
Last updated
2025-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eye Movement

Brief summary

This is an observational prospective study in a cohort of healthy subjects who are enrolled using convenience and snowballing sampling. The aims of the study is to demonstrate the efficacy of using NeuraLight system to capture oculometric data from healthy participants and to validate the data capture of NeuraLight oculometric measurements as compared with a validated eye-tracker system in subjects who meet the inclusion criteria and who provide a signed Informed Consent.

Detailed description

The purpose of the trial is to demonstrate the efficacy of using NeuraLight system to capture oculometric data from healthy participants, and to validate the data capture of NeuraLight oculometric measurements as compared with a validated eye-tracker system. In addition, we also aim to collect oculometric data from healthy participants in order to optimize a regression model which can be used for future prediction of clinical endpoints in various neurological patients at different stages of disease

Interventions

NeuraLight is an investigational software-based platform used for measuring eye movements in response to visual stimuli and captured using a simple webcam

Sponsors

NeuraLight
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years

Inclusion criteria

* Men and women ages between 18 and 90 years old * Normal or corrected vision * Ability to follow instructions * Willing and able to sign an informed consent form

Exclusion criteria

* Inability to sit for 20 minutes on a chair in a calm manner * Personal or 1st degree relative history of epilepsy * Additional neurological diseases * Drug or alcohol abuse

Design outcomes

Primary

MeasureTime frameDescription
Efficacy of data capture36 monthsCapturing \>50 different oculometric measures in \>95% of a cohort of up to 2000 subjects
Validation of data capture36 monthsRelative root mean square error (RMSE) of NeuraLight's extracted oculometric measures compared with retrieved measurements from a validated eye tracking system \<0.1

Secondary

MeasureTime frameDescription
Optimization of data capture36 monthsOptimization of a feature selection model (Fisher's Linear Discriminant Analysis (LDA)) on NeuraLight oculometric measures used for a logistic regression model of clinical endpoints with a relative root mean square error (RMSE) of \<0.1

Countries

United States

Contacts

Primary ContactEitan Raveh, PhD
eitan@neuralight.ai+972-58-6277947

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026